04 August 2021>: Animal Study
Se-Methylselenocysteine Alleviates Liver Injury in Diethylnitrosamine (DEN)-Induced Hepatocellular Carcinoma Rat Model by Reducing Liver Enzymes, Inhibiting Angiogenesis, and Suppressing Nitric Oxide (NO)/Nitric Oxide Synthase (NOS) Signaling Pathway
Jun Ding 1ABCDEFG** , Chuang Qi 2BCDEF* , Jinmao Li 1BCDF , Chuying Huang 2BCD , Jiayao Zhang 1BCF , Yong Zhang 1BC , Yi Li 1BCF , Bin Fan 1CFDOI: 10.12659/MSM.929255
Med Sci Monit 2021; 27:e929255
Figure 8 Se-methylselenocysteine (MSC) treatments reduced serum levels of nitric oxide (NO) and nitric oxide synthase (NOS) in rats of different groups. (A) Statistical analysis of serum NO levels. (B) Statistical analysis of serum NOS levels. # P<0.05 vs Normal control group. * P<0.05 vs Model group.